Special Supplement, October 2022

Articles

• 

  Panel Discussion: Treatment options for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) patients

  Ronan Foley, MD, FRCPC, Carolyn Owen, MD, FRCPC, Samer Tabchi, MD, Ghazaleh Shoja E. Razavi, MD, PhD

  • PDF (en)